MAX Chat
Company Analysis Astec LifeSciences Limited
1. Summary
Disadvantages
- Price (788.9 βΉ) is higher than fair price (319.58 βΉ)
- Dividends (0%) are below the sector average (1.09%).
- The stock's return over the last year (-35.4%) is lower than the sector average (9.45%).
- Current debt level 50.66% has increased over 5 years from 38.17%.
- The company's current efficiency (ROE=-11.9%) is lower than the sector average (ROE=9.91%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Astec LifeSciences Limited | Materials | Index | |
|---|---|---|---|
| 7 days | -2.8% | 0% | -1.2% |
| 90 days | 13.2% | 18.4% | 4.6% |
| 1 year | -35.4% | 9.5% | 2% |
ASTEC vs Sector: Astec LifeSciences Limited has significantly underperformed the "Materials" sector by -44.86% over the past year.
ASTEC vs Market: Astec LifeSciences Limited has significantly underperformed the market by -37.38% over the past year.
Stable price: ASTEC is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ASTEC with weekly volatility of -0.6808% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (788.9 βΉ) is higher than the fair price (319.58 βΉ).
Price is higher than fair: The current price (788.9 βΉ) is 59.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (92.7) is higher than that of the sector as a whole (48.94).
P/E vs Market: The company's P/E (92.7) is higher than that of the market as a whole (66.04).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (5.94) is higher than that of the sector as a whole (5.42).
P/BV vs Market: The company's P/BV (5.94) is lower than that of the market as a whole (6.6).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (4.79) is higher than that of the sector as a whole (3.75).
P/S vs Market: The company's P/S indicator (4.79) is lower than that of the market as a whole (18.95).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-10011.79) is lower than that of the sector as a whole (-40.36).
EV/Ebitda vs Market: The company's EV/Ebitda (-10011.79) is lower than that of the market as a whole (24.96).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -39.76% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-39.76%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.9%).
5.4. ROE
ROE vs Sector: The company's ROE (-11.9%) is lower than that of the sector as a whole (9.91%).
ROE vs Market: The company's ROE (-11.9%) is lower than that of the market as a whole (3.54%).
5.5. ROA
ROA vs Sector: The company's ROA (-4.8%) is lower than that of the sector as a whole (7.18%).
ROA vs Market: The company's ROA (-4.8%) is lower than that of the market as a whole (7.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (3.75%) is lower than that of the sector as a whole (14.6%).
ROIC vs Market: The company's ROIC (3.75%) is lower than that of the market as a whole (15.45%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.09%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (11.5%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
